Donate to the CBC

Thank you for your interest in donating to the Chicago Biomedical Consortium (CBC).

Donate

Since its launch in 2006, the CBC has received most of its funding from a generous grant from the Searle Funds at The Chicago Community Trust and from the three universities participating in the consortium: Northwestern University, The University of Chicago, and the University of Illinois Chicago (UIC).

The CBC welcomes and greatly appreciates additional financial contributions to supplement its available funds. Your gift to support the CBC will help us sustain the activities that are strengthening innovative biomedical research in Chicago.
 

Donation Questions? Please contact:

Michelle Hoffmann
michelle.hoffmann@northwestern.edu

Kimberly Corn
k-corn@northwestern.edu

Our Donors
Searle Funds logo          The Searle Funds at The Chicago Community Trust

    The CBC was launched in 2006 with a generous annual grant award from the Searle Funds at The Chicago Community Trust. To date, more than $81 million has been invested into CBC initiatives to promote Chicago’s biomedical community resulting in more than 374 awards granted, over 2,715 research papers published, six national research centers established, CBC-HITES, a NIH Research Evaluation and Commercialization Hub (REACH) launched in 2024, and over $944 million dedicated to research funding.


Walder Ventures logo          The Walder Foundation

    The Walder Foundation was established by Joseph and Elizabeth Walder to address critical issues impacting our world. The Foundation’s five areas of focus—science innovation, environmental sustainability, the performing arts, migration and immigrant communities, and Jewish life—are an extension of the Walders’ lifelong passions, interests, and their personal and professional experiences.


NIH logo          National Institutes of Health REACH Funding:

    REAC Hubs – Research Evaluation and Commercialization Hubs (REACH) support academic innovators to convert promising scientific discoveries into medical products while training a biomedical workforce that is globally competitive in technology development and entrepreneurship.